Schulze-Bergkamen, H; Fleischer, B; Schuchmann, M et al.
Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.BMC Cancer. Bd. 6. 2006 S. 232
Fottner, C; Helisch, A; Minnemann, T et al.
Targeted peptide receptor radionuclide for advanced neuroendocrine tumors (NET) with 90 Y-DOTATOC - tumor response and clinical benefit. 50th Annual Meeting of the German Society of EndocrinologyExp Diabesity Res. Bd. 114. 2006 S. P05-069
Müller, M; Meyer, M; Schilling, T et al.
Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.Int J Oncol. Bd. 29. H. 4. 2006 S. 973-80
Becker, CH; Fantini, MC; Neurath, MF
TGF-beta as a T cell regulator in colitis and colon cancer.Cytokine Growth Factor Rev. Bd. 17. H. 1-2. 2006 S. 97-106
Neurath, Markus F.; Finotto, Susetta
The many roads to inflammatory bowel diseasesImmunity. Bd. 25. H. 2. Cambridge, Mass.: Cell Press 2006 S. 189 - 191
Strub, A; Ulrich, WR; Hesslinger, C et al.
The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.Mol Pharmacol. Bd. 69. H. 1. 2006 S. 328-337
Schulze-Bergkamen, H; Schuchmann, M; Fleischer, B et al.
The role of apoptosis versus oncotic necrosis in liver injury: facts or faith?J Hepatol. Bd. 44. H. 5. 2006 S. 984-93
Dittmar, M; Kaczmarczyk, A; Bischofs, C et al.
The TNF-alpha -308 A allele confers susceptibility to polyglandular autoimmunityExp Clin Endocr Diab. H. S1. 2006 S. P12
Holtmann, MH; Franzaring, L; Kiesslich, R et al.
Tonnenkonkremente im Ductus choledochus bei einer 4 Jahre vergessenen, impaktierten EndoprotheseZ Gastroenterol. Bd. 44. H. 10. 2006 S. 1043-1045
Casola, S; Cattoretti, G; Uyttersprot, N et al.
Tracking germinal center B cells expressing germ-line immunoglobulin gamma1 transcripts by conditional gene targeting.Proc Natl Acad Sci U S A. Bd. 103. H. 19. 2006 S. 7396-401